These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Mixed urinary incontinence: A prospective study on the effect of trans-obturator mid-urethral sling. Natale F; Illiano E; La Penna C; Balsamo R; Costantini E Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():64-69. PubMed ID: 29248808 [TBL] [Abstract][Full Text] [Related]
27. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial. Herschorn S; Swift S; Guan Z; Carlsson M; Morrow JD; Brodsky M; Gong J BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103 [TBL] [Abstract][Full Text] [Related]
28. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug. Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155 [TBL] [Abstract][Full Text] [Related]
29. Central inhibition of refractory overactive bladder complaints, results of an inpatient training program. Meijer EF; Nieuwhof-Leppink AJ; Dekker-Vasse E; de Joode-Smink GC; de Jong TP J Pediatr Urol; 2015 Feb; 11(1):21.e1-5. PubMed ID: 25205144 [TBL] [Abstract][Full Text] [Related]
30. Comparison of fesoterodine and tolterodine in patients with overactive bladder. Chapple CR; Van Kerrebroeck PE; Jünemann KP; Wang JT; Brodsky M BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298 [TBL] [Abstract][Full Text] [Related]
31. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. MacDiarmid S; Staskin DR; Lucente V; Kaaki B; English S; Gilling P; Meffan P; Clark M; Sand PK; Sen SK; Rovner E J Urol; 2019 May; 201(5):967-972. PubMed ID: 31009968 [TBL] [Abstract][Full Text] [Related]
32. Different electrode positioning for transcutaneous electrical nerve stimulation in the treatment of urgency in women: a study protocol for a randomized controlled clinical trial. Padilha JF; Avila MA; Seidel EJ; Driusso P Trials; 2020 Feb; 21(1):166. PubMed ID: 32046754 [TBL] [Abstract][Full Text] [Related]
33. Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected]. MacDiarmid S; Al-Shukri S; Barkin J; Fianu-Jonasson A; Grise P; Herschorn S; Saleem T; Huang M; Siddiqui E; Stölzel M; Hemsted C; Nazir J; Hakimi Z; Drake MJ; J Urol; 2016 Sep; 196(3):809-18. PubMed ID: 27063854 [TBL] [Abstract][Full Text] [Related]
34. Urodynamic findings in women with refractory overactive bladder symptoms. Al-Zahrani AA; Gajewski J Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863 [TBL] [Abstract][Full Text] [Related]
35. Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms. Rovner ES; Kreder K; Sussman DO; Kaplan SA; Carlsson M; Bavendam T; Guan Z J Urol; 2008 Sep; 180(3):1034-41. PubMed ID: 18639297 [TBL] [Abstract][Full Text] [Related]
36. The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity. Choe JH; Choo MS; Lee KS J Urol; 2008 Jan; 179(1):214-9. PubMed ID: 18001792 [TBL] [Abstract][Full Text] [Related]
37. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study. Sand P; Zinner N; Newman D; Lucente V; Dmochowski R; Kelleher C; Dahl NV BJU Int; 2007 Apr; 99(4):836-44. PubMed ID: 17187655 [TBL] [Abstract][Full Text] [Related]
38. Correlation between psychological stress levels and the severity of overactive bladder symptoms. Lai H; Gardner V; Vetter J; Andriole GL BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525 [TBL] [Abstract][Full Text] [Related]
39. Combined Tolterodine and Vaginal Estradiol Cream for Overactive Bladder Symptoms After Randomized Single-Therapy Treatment. Ellington DR; Szychowski JM; Malek JM; Gerten KA; Burgio KL; Richter HE Female Pelvic Med Reconstr Surg; 2016; 22(4):254-60. PubMed ID: 26945271 [TBL] [Abstract][Full Text] [Related]
40. Ultrasound measurement of bladder wall thickness is associated with the overactive bladder syndrome. Panayi DC; Tekkis P; Fernando R; Hendricken C; Khullar V Neurourol Urodyn; 2010 Sep; 29(7):1295-8. PubMed ID: 20127835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]